Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Localized Clear Cell Renal Cell Carcinoma”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Testing effectiveness (Phase 2)Looking for participantsNCT07226544
What this trial is testing

Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer

Who this might be right for
Localized Clear Cell Renal Cell CarcinomaResectable Clear Cell Renal Cell CarcinomaStage II Renal Cell Cancer AJCC v8+2 more
City of Hope Medical Center 31
Not applicableUnknownNCT00945984
What this trial is testing

Laparoendoscopic Single-site Radical Nephrectomy for Localized Renal Cell Carcinoma

Who this might be right for
Localized Renal Cell Carcinoma
Seoul National University Hospital 36
Early research (Phase 1)Study completedNCT01497444
What this trial is testing

Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Kidney CancerLiver Cancer
Alliance for Clinical Trials in Oncology 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07741617
What this trial is testing

A Prospective, Single-Arm, Multicenter Clinical Study of High-Risk Localized and Locally Advanced Renal Clear Cell Carcinoma

Who this might be right for
Urologic Neoplasms
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 54
Large-scale testing (Phase 3)Study completedNCT04394975
What this trial is testing

Study to Evaluate the Efficacy and Safety of Toripalimab in Combination With Axitinib Versus Sunitinib Monotherapy in Advanced Renal Cell Cancer

Who this might be right for
Primary Disease: Unresectable or Metastatic Renal Cell Carcinoma Focus of the Study:PFS Assessed by IRC Per RECIST 1.1
Shanghai Junshi Bioscience Co., Ltd. 421
Not applicableWithdrawnNCT01769885
What this trial is testing

Tivozanib Before Surgery in Treating Patients With Localized Kidney Cancer

Who this might be right for
Stage II Renal Cell CancerStage III Renal Cell Cancer
Roswell Park Cancer Institute
Not applicableUnknownNCT04946266
What this trial is testing

Prospective Validation of the Prognostic Value of Long Non-coding MFI2-AS1 RNA in Localized Clear Cell Kidney Cancers

Who this might be right for
Kidney Cancer
University Hospital, Strasbourg, France 260
Large-scale testing (Phase 3)Study completedNCT00002764
What this trial is testing

Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerKidney CancerMetastatic Cancer+3 more
European Organisation for Research and Treatment of Cancer - EORTC 340
Not applicableWithdrawnNCT04688333
What this trial is testing

IConquerFear Program for the Treatment of Fear of Cancer Recurrence in Patients With Localized Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
City of Hope Medical Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07627464
What this trial is testing

Anlotinib + Benmelstobart vs Surgery for Patients With Localized Renal Cell Carcinoma Scheduled to Undergo Partial Nephrectomy

Who this might be right for
Renal Cell Carcinoma (RCC)
Tianjin Medical University Cancer Institute and Hospital 144
Large-scale testing (Phase 3)Active Not RecruitingNCT05863351
What this trial is testing

Focused Radiation Versus Systemic Therapy for Kidney Cancer Patients With Limited Metastasis, SOAR Study

Who this might be right for
Metastatic Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8
ECOG-ACRIN Cancer Research Group 472
Large-scale testing (Phase 3)Study completedNCT01235962
What this trial is testing

Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Who this might be right for
Renal Cell Carcinoma (RCC)Cancer
Novartis Pharmaceuticals 1,538
Not applicableStudy completedNCT00806650
What this trial is testing

Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
City of Hope Medical Center 155
Not applicableEnded earlyNCT02138578
What this trial is testing

Trial Comparing Stereotactic Body Radiation Therapy to Radiofrequency Ablation for Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
University of Michigan Rogel Cancer Center 4
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Not applicableStudy completedNCT00253383
What this trial is testing

Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients

Who this might be right for
Cancer
Dartmouth-Hitchcock Medical Center 329
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)UnknownNCT02613819
What this trial is testing

Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney

Who this might be right for
Renal Cell Carcinoma
Trans Tasman Radiation Oncology Group 71
Early research (Phase 1)Study completedNCT00004178
What this trial is testing

Gene Therapy in Treating Patients With Cancer

Who this might be right for
Cancer
Roger Williams Medical Center
Large-scale testing (Phase 3)Active Not RecruitingNCT03055013
What this trial is testing

Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy

Who this might be right for
Metastatic Renal Cell CarcinomaSarcomatoid Renal Cell CarcinomaStage II Renal Cell Cancer AJCC v7+2 more
National Cancer Institute (NCI) 819
Next Page